4.7 Article

Biosynthesis of a Therapeutically Important Nicotinamide Mononucleotide through a Phosphoribosyl Pyrophosphate Synthetase 1 and 2 Engineered Strain of Escherichia coli

期刊

ACS SYNTHETIC BIOLOGY
卷 10, 期 11, 页码 3055-3065

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acssynbio.1c00333

关键词

nicotinamide mononucleotide; phosphoribosyl pyrophosphate synthetase; response surface methodology; E. coli

资金

  1. National Research Foundation of Korea [NRF-2019R1I1A3A02058523]

向作者/读者索取更多资源

The study successfully constructed a recombinant strain of E. coli with inserted NAMPT, PRPS1, and PRPS2 genes, achieving efficient NMN production in batch fermentation studies. Further investigation showed that supplementation of ribose, Mg2+, phosphate, nicotinamide, and lactose inducer led to a significant increase in NMN production levels.
Nicotinamide mononucleotide (NMN), a precursor of NAD(+), can be synthesized by the conversion of nicotinamide with the help of nicotinamide phosphoribosyl transferase (NAMPT) via the salvage pathway. NMN has recently gained great attention as an excellent therapeutic option due to its long-term effective pharmacological activities. In this study, we constructed a recombinant strain of Escherichia coli by inserting NAMPT and phosphoribosyl pyrophosphate synthetase 1 (PRPS1) and PRPS2 (from Homo sapiens) genes to investigate the effect of PRPS1 and PRPS2 on NMN synthesis. The metabolically engineered strain of E. coli BL21 (DE3) exhibited 1.57 mM NMN production in the presence of Mg2+ and phosphates in batch fermentation studies. For further improvement in NMN production levels, effects of different variables were studied using a response surface methodology approach. A significant increment was achieved with a maximum of 2.31 mM NMN production when supplemented with 1% ribose, 1 mM Mg2+ and phosphate, and 0.5% nicotinamide in the presence of a lactose (1%) inducer. Additionally, insertion of the PRPS1 and PRPS2 genes in the phosphoribosyl pyrophosphate synthesis pathway and individual gene expression studies facilitated a higher NMN production at the intracellular level than the reported studies. The strain exhibited intracellular production of NMN from cheap substrates such as glucose, lactose, and nicotinamide. Hence, the overall optimized process can be further scaled up for the economical production of NMN using a recombinant strain of E. coli BL21 (DE3), which is the future perspective of the current study.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据